Janus Henderson Group PLC Collegium Pharmaceutical, Inc Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 430,481 shares of COLL stock, worth $14.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
430,481
Previous 291,388
47.73%
Holding current value
$14.2 Million
Previous $8.35 Million
53.92%
% of portfolio
0.01%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding COLL
# of Institutions
252Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$191 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$98.8 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$86.9 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$74 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$53.8 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.12B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...